New research shows that the CHA(2)DS(2)VASc score can effectively predict the risk of serious heart events in patients who do not have atrial fibrillation.
A study involved 468 outpatients over an average of 12 months, revealing a notable incidence of major adverse cardiac outcomes linked to higher CHA(2)DS(2)VASc scores.
Patients with a score of 6 or more had a significantly increased risk (over 4 times) of experiencing serious complications compared to those with lower scores.